A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
Clinical trial NCT06984718 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06984718
- Sponsor
- Akeso
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2026-11-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.